Akebia Therapeutics, Inc. (AKBA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.26
Day's range
$1.37

Akebia Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 18.69 M $25.98 M   -3.24% 7.27%
STATE STREET CORP 05/15/2026 11.61 M $16.14 M   -15.15% 4.52%
05/15/2026 11.17 M $15.52 M   100.00% 4.34%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 6.45 M $8.97 M   2.79% 2.51%
GOLDMAN SACHS GROUP INC 05/15/2026 3.60 M $5.01 M   -23.45% 1.40%
CITIGROUP INC 05/11/2026 2.85 M $3.97 M   17.17% 1.11%
BANK OF AMERICA CORP /DE/ 05/18/2026 2.76 M $3.84 M   22.41% 1.07%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 2.40 M $3.33 M   -19.91% 0.93%
MILLENNIUM MANAGEMENT LLC 05/15/2026 2.38 M $3.31 M   44.22% 0.93%
05/08/2026 2.22 M $3.08 M   100.00% 0.86%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 2.02 M $2.80 M   -7.58% 0.78%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 2.00 M $2.78 M   0.00% 0.78%
NORTHERN TRUST CORP 05/14/2026 1.95 M $2.70 M   -15.89% 0.76%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 1.83 M $2.55 M   -48.98% 0.71%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 1.79 M $2.49 M   177.20% 0.70%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.78 M $2.47 M   100.00% 0.69%
JANE STREET GROUP, LLC 05/12/2026 1.46 M $2.02 M   110.63% 0.57%
CITADEL ADVISORS LLC 05/15/2026 1.39 M $1.93 M   -70.21% 0.54%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 1.38 M $1.91 M   -37.40% 0.54%
FMR LLC 05/15/2026 1.34 M $1.86 M   18.63% 0.52%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.30 M $1.80 M   1,332.15% 0.50%
HRT FINANCIAL LP 05/14/2026 976.94 K $1.36 M   -39.67% 0.38%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 921.92 K $1.28 M   -41.32% 0.36%
UBS GROUP AG 05/05/2026 769.47 K $1.07 M   -11.71% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 722.12 K $1.00 M   11.49% 0.28%
INVESCO LTD. 05/12/2026 720.14 K $1.00 M   7.61% 0.28%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 707.75 K $983.77 K   -10.01% 0.28%
VOLEON CAPITAL MANAGEMENT LP 05/15/2026 675.66 K $939.16 K   149.04% 0.26%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 665.63 K $925.23 K   -8.87% 0.26%
BANK OF NEW YORK MELLON CORP 05/05/2026 650.85 K $904.68 K   -2.41% 0.25%
HENNION & WALSH ASSET MANAGEMENT, INC. 05/13/2026 633.25 K $880.22 K   26.91% 0.25%
LOS ANGELES CAPITAL MANAGEMENT LLC 05/08/2026 601.31 K $835.82 K   1,930.97% 0.23%
NUVEEN, LLC 04/30/2026 596.60 K $829.27 K   0.61% 0.23%
MORGAN STANLEY 05/15/2026 581.33 K $808.04 K   -52.69% 0.23%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 429.67 K $597.24 K   -34.68% 0.17%
SQUAREPOINT OPS LLC 05/15/2026 422.83 K $587.73 K   -65.43% 0.16%
AMERICAN CENTURY COMPANIES INC 05/15/2026 415.99 K $578.22 K   0.00% 0.16%
MANGROVE PARTNERS 05/15/2026 375.95 K $522.58 K   100.00% 0.15%
RAFFERTY ASSET MANAGEMENT, LLC 05/15/2026 327.11 K $454.68 K   -34.40% 0.13%
VIRTUS ETF ADVISERS LLC 05/14/2026 308.00 K $428.12 K   100.00% 0.12%
RHUMBLINE ADVISERS 05/12/2026 306.93 K $426.62 K   -3.31% 0.12%
CANADA PENSION PLAN INVESTMENT BOARD 05/15/2026 287.50 K $399.63 K   -10.96% 0.11%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 274.43 K $381.46 K   -63.60% 0.11%
MAN GROUP PLC 05/15/2026 257.85 K $358.42 K   23.61% 0.10%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 249.16 K $347.00 K   17.15% 0.10%
GRAHAM CAPITAL MANAGEMENT, L.P. 05/15/2026 248.35 K $345.21 K   -34.05% 0.10%
XTX TOPCO LTD 05/15/2026 244.45 K $339.79 K   -48.26% 0.10%
ALLIANCEBERNSTEIN L.P. 05/15/2026 238.93 K $384.68 K   0.00% 0.09%
PANAGORA ASSET MANAGEMENT INC 05/14/2026 236.11 K $328.19 K   0.00% 0.09%
ALPS ADVISORS INC 05/08/2026 218.07 K $303.12 K   0.08% 0.08%

Akebia Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 245 institutional investors and hedge funds held shares of Akebia Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 18.69 M

STATE STREET CORP: 11.61 M

GEODE CAPITAL MANAGEMENT, LLC: 6.45 M

GOLDMAN SACHS GROUP INC: 3.6 M

CITIGROUP INC: 2.85 M

BANK OF AMERICA CORP /DE/: 2.76 M

39.55% of Akebia Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 127.71 M shares in the last 24 months. This purchase volume represents approximately $172.41 M in transactions.